Microneedle-based vaccines.
暂无分享,去创建一个
Michel Cormier | Mark R Prausnitz | Alexander K Andrianov | M. Prausnitz | A. Andrianov | J. Mikszta | M. Cormier | John A Mikszta | J. A. Mikszta
[1] P. Ellner. Smallpox: Gone but not forgotten , 1998, Infection.
[2] J. Hooper,et al. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge , 2006, Vaccine.
[3] P. Thongcharoen,et al. Antibody responses after dose-sparing intradermal influenza vaccination. , 2007, Vaccine.
[4] J. Stockman. Dose Sparing With Intradermal Injection of Influenza Vaccine , 2006 .
[5] Chun-Ming Huang. Topical vaccination: the skin as a unique portal to adaptive immune responses , 2007, Seminars in Immunopathology.
[6] Bai Xu,et al. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. , 2005, Nanomedicine : nanotechnology, biology, and medicine.
[7] M. Cormier,et al. Macroflux Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines , 2002 .
[8] J. Yoshimitsu,et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.
[9] P. Lambert,et al. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. , 2005, The Journal of hospital infection.
[10] M. Cormier,et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.
[11] M. Cormier,et al. Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.
[12] Takaya Miyano,et al. Sugar Micro Needles as Transdermic Drug Delivery System , 2005, Biomedical microdevices.
[13] Wijaya Martanto,et al. Mechanism of fluid infusion during microneedle insertion and retraction. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[14] M. Allen,et al. Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.
[15] J. Birchall,et al. Gene Delivery to the Epidermal Cells of Human Skin Explants Using Microfabricated Microneedles and Hydrogel Formulations , 2008, Pharmaceutical Research.
[16] R. Larke,et al. Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease. , 1979, The Journal of infectious diseases.
[17] Jung-Hwan Park,et al. Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.
[18] Michael D. Menger,et al. Clinically Applied Microcirculation Research , 1995 .
[19] D. Waag,et al. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines. , 1994, Laboratory animal science.
[20] Jung-Hwan Park,et al. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[21] Vincent J. Sullivan,et al. Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.
[22] Regina Luttge,et al. Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .
[23] T. Monath,et al. Yellow fever vaccine , 2005, Reactions Weekly.
[24] A. Vølund,et al. Induction of formaldehyde contact sensitivity: dose response relationship in the guinea pig maximization test. , 1985, Acta dermato-venereologica.
[25] J. Hadgraft,et al. Modified-Release Drug Delivery Technology , 2002 .
[26] Sion A. Coulman,et al. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. , 2006, Critical reviews in therapeutic drug carrier systems.
[27] R. Stoughton. Percutaneous absorption: Mechanisms—methodology-drug delivery, Bronaugh Robert L., Howard I. Maibach (Eds.). Marcel Dekker Inc., New York (1989), 632, $125.00 , 1990 .
[28] Sion A. Coulman,et al. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. , 2006, Current drug delivery.
[29] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[30] Kwok-Hung Chan,et al. Immunogenicity and Safety of Intradermal Influenza Immunization at a Reduced Dose in Healthy Children , 2007, Pediatrics.
[31] Anthony S. Fauci,et al. Pandemic Influenza Threat and Preparedness , 2006, Emerging infectious diseases.
[32] J. Bouwstra,et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[33] Melissa Ai Ling Teo,et al. In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.
[34] Rino Rappuoli,et al. Vaccine manufacturing: challenges and solutions , 2006, Nature Biotechnology.
[35] K. Sugibayashi,et al. Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. , 2006, International journal of pharmaceutics.
[36] M Shirkhanzadeh,et al. Microneedles coated with porous calcium phosphate ceramics: Effective vehicles for transdermal delivery of solid trehalose , 2005, Journal of materials science. Materials in medicine.
[37] H. Maibach,et al. Percutaneous Penetration Enhancers: An Overview , 2007, Skin Pharmacology and Physiology.
[38] Wijaya Martanto,et al. Microinfusion Using Hollow Microneedles , 2006, Pharmaceutical Research.
[39] Dorian Liepmann,et al. Microneedles and transdermal applications , 2007, Expert opinion on drug delivery.
[40] W. James,et al. Microbiology of the skin: resident flora, ecology, infection. , 1989, Journal of the American Academy of Dermatology.
[41] Mark G. Allen,et al. Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.
[42] R. Rappuoli,et al. Novel Approaches to Vaccine Delivery , 2004, Pharmaceutical Research.
[43] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] Cheryl H. Dean,et al. Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates , 2005, Human vaccines.
[45] Jung-Hwan Park,et al. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[46] M. Goldfield,et al. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. , 1979, American journal of public health.
[47] Vincent J. Sullivan,et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. , 2005, The Journal of infectious diseases.
[48] Howard I. Maibach,et al. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods, Fourth Edition , 2005 .
[49] Mark R Prausnitz,et al. Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[50] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[51] Jeffrey D Zahn,et al. Microneedle Insertion Force Reduction Using Vibratory Actuation , 2004, Biomedical microdevices.
[52] R. Balicer,et al. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. , 2007, Vaccine.
[53] Howard I. Maibach,et al. Models in dermatology , 1987 .
[54] E. D. Barnhart. Physicians Desk Reference , 1990 .
[55] Robert Langer,et al. Transdermal drug delivery , 2008, Nature Biotechnology.
[56] Kanji Takada,et al. Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] F. Newman,et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. , 2007, Vaccine.
[58] S. Mitragotri,et al. Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.
[59] Mark R. Prausnitz,et al. Coating Formulations for Microneedles , 2007, Pharmaceutical Research.
[60] Adriana T Larregina,et al. Changing paradigms in cutaneous immunology: adapting with dendritic cells. , 2005, The Journal of investigative dermatology.
[61] K. Sugibayashi,et al. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[62] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[63] R. Webster,et al. Are We Ready for Pandemic Influenza? , 2003, Science.
[64] Dorian Liepmann,et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[65] Mark R Prausnitz,et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. , 2004, Journal of biomechanics.
[66] Larry K. Pickering,et al. General recommendations on immunization. , 2006, MMWR. Morbidity and mortality weekly report.
[67] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[68] F. Nestle,et al. Deepening our understanding of immune sentinels in the skin. , 2007, The Journal of clinical investigation.
[69] Wijaya Martanto,et al. Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.
[70] Mark R Prausnitz,et al. Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles , 2008, Advanced materials.
[71] P. Laurent,et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. , 2007, Vaccine.
[72] Michael L. Reed,et al. Microsystems for drug and gene delivery , 2004, Proceedings of the IEEE.
[73] J. Stockman. Serum Antibody Responses After Intradermal Vaccination Against Influenza , 2006 .
[74] N. Harvey,et al. Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines , 2007, Clinical and Vaccine Immunology.
[75] Mark R Prausnitz,et al. Precise microinjection into skin using hollow microneedles. , 2006, The Journal of investigative dermatology.
[76] Mark R Prausnitz,et al. Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.
[77] Benjamin Schwartz,et al. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[78] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[79] B. Murphy,et al. Development of effective vaccines against pandemic influenza. , 2006, Immunity.
[80] Anthony Morrissey,et al. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles , 2005, Journal of drug targeting.
[81] P. Lambert,et al. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? , 2008, Vaccine.
[82] T. Horio,et al. A New Animal Model for Contact Dermatitis: The Hairless Guinea Pig , 1992, The Journal of dermatology.
[83] Göran Stemme,et al. Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.
[84] Mark R Prausnitz,et al. Pocketed Microneedles for Drug Delivery to the Skin. , 2008, The Journal of physics and chemistry of solids.
[85] James C Birchall,et al. Microneedle array technology: the time is right but is the science ready? , 2006, Expert review of medical devices.
[86] A. Fauci,et al. Intradermal influenza vaccination--can less be more? , 2004, The New England journal of medicine.
[87] D. Pickup. Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design , 2007, Expert review of vaccines.
[88] M. Prausnitz,et al. Microneedles for Drug Delivery , 2008 .
[89] Lawrence O Gostin,et al. Medical countermeasures for pandemic influenza: ethics and the law. , 2006, JAMA.
[90] D. Barrow,et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery , 2004, The British journal of dermatology.
[91] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[92] J. Díaz-Ortega,et al. The relationship between dose and response of standard measles vaccines. , 1994, Biologicals : journal of the International Association of Biological Standardization.
[93] C. Sabella,et al. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. , 1993, The Journal of infectious diseases.
[94] Mark R. Prausnitz,et al. Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.
[95] R. Couch,et al. The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. , 1977, The Journal of infectious diseases.
[96] F. Guirakhoo,et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. , 2003, The Journal of infectious diseases.
[97] Mark R Prausnitz,et al. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. , 2005, Diabetes technology & therapeutics.